Lamotrigine Desitin

Lamotrigine, the active ingredient in Lamotrigine Desitin, is a sodium channel blocker presented as an oral formulation for oral use. It treats epilepsy and bipolar disorder in adults and children as prescribed.

GNH USA supplies Lamotrigine Desitin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is used in the management of seizure disorders and mood stabilization, acting on neuronal sodium channels to reduce hyperexcitability. - Epilepsy: decreases the frequency and severity of partial and generalized seizures. - Bipolar disorder: helps maintain mood stability and reduces depressive and manic episodes. - Adjunctive therapy: used alongside other antiepileptic drugs when monotherapy is insufficient.

Lamotrigine may cause a range of adverse reactions, from mild to severe. Awareness of these effects supports safe use.

Common Side Effects: - Dizziness - Headache - Nausea - Rash (mild) - Blurred vision - Insomnia

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., bullous eruptions) - Blood dyscrasias such as agranulocytosis - Hepatic failure - Suicidal thoughts or behavior - Severe hypersensitivity reactions

Before initiating lamotrigine therapy, consider patient‑specific factors and monitoring requirements. - Pregnancy: consult prescriber; limited safety data are available. - Renal impairment: dose adjustment may be required. - Hepatic impairment: monitor liver function and adjust dose as needed. - Concomitant valproic acid: may increase lamotrigine plasma levels; close monitoring is essential. - Avoid abrupt discontinuation: risk of seizure recurrence or mood destabilization. - Store below 25°C: keep in the original pack, protect from moisture.

Lamotrigine interacts with several medicines that can alter its plasma concentration or therapeutic effect.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising toxicity risk. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy. - Oral contraceptives: lamotrigine may lower hormonal effectiveness. - Phenobarbital: accelerates lamotrigine metabolism, lowering exposure. - Phenytoin: enhances lamotrigine clearance, diminishing therapeutic effect.

Moderate Interactions (Monitor Closely): - Serotonergic agents (e.g., SSRIs, MAO inhibitors): may increase risk of serotonin syndrome. - Other antiepileptic drugs: combined use may require dose adjustments and therapeutic drug monitoring.